You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

idelalisib

Showing 51 - 68 of 68
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Quality of Life of Lymphomas Treated With Oral Therapy

Recruiting
  • Quality of Life
  • Questionnaire
  • Toulouse 9, France
    Loïc YSEBAERT
Apr 22, 2022

Relapsed/Refractory Mantle Cell Lymphoma Trial in United States (lenalidomide, idelalisib)

Completed
  • Relapsed/Refractory Mantle Cell Lymphoma
  • Chicago, Illinois
  • +3 more
Jan 26, 2018

Chronic Lymphocytic Leukemia Trial in Worldwide (Idelalisib, Bendamustine, Rituximab)

Terminated
Has Results
  • Chronic Lymphocytic Leukemia
  • Idelalisib
  • +3 more
  • Fullerton, California
  • +90 more
Oct 19, 2018

Indolent Non-Hodgkin's Lymphomas Trial in Worldwide (Placebo, Rituximab, Idelalisib)

Terminated
Has Results
  • Indolent Non-Hodgkin's Lymphomas
  • Placebo
  • +2 more
  • Huntsville, Alabama
  • +102 more
Oct 19, 2018

Advanced Solid Tumor Trial in Shanghai (YY-20394)

Unknown status
  • Advanced Solid Tumor
  • Shanghai, Shanghai, China
    Shanghai East Hospital
Aug 7, 2019

Amyloidosis Trial in Boston (Idelalisib)

Terminated
Has Results
  • Amyloidosis
  • Idelalisib
  • Boston, Massachusetts
    Boston Medical Center
Aug 23, 2017

Non Small Cell Lung Cancer, Metastasis, Recurrence Trial in Augusta (Pembrolizumab, Idelalisib)

Unknown status
  • Non Small Cell Lung Cancer
  • +2 more
  • Augusta, Georgia
    Georgia Cancer Center at Augusta University
Sep 27, 2017

Autoimmune Cytopenia and BcR Inhibitors

Unknown status
  • Autoimmune Cytopenia Associated With Chronic Lymphocytic Leukemia
  • ibrutinib ou idelalisib
  • Marseille, Bouches Du Rhone, France
    Institut Paoli Calmettes
Mar 16, 2018

Indolent Non-Hodgkin's Lymphomas Trial in Worldwide (Idelalisib, Rituximab, Bendamustine)

Terminated
Has Results
  • Indolent Non-Hodgkin's Lymphomas
  • Idelalisib
  • +3 more
  • Huntsville, Alabama
  • +143 more
Oct 19, 2018

Follicular Lymphoma, Relapsed/Refractory Follicular Lymphoma Trial in Worldwide

Recruiting
  • Follicular Lymphoma
  • Relapsed/Refractory Follicular Lymphoma
    • Split, Croatia
    • +10 more
    Oct 8, 2020

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in La Jolla (dimethyl fumarate)

    Terminated
    Has Results
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • dimethyl fumarate
    • La Jolla, California
      UC San Diego Moores Cancer Center
    Aug 16, 2019

    B-cell Lymphoma Recurrent, B-cell Chronic Lymphocytic Leukemia Trial in Beijing, Nanjing, Tianjin (YY-20394)

    Unknown status
    • B-cell Lymphoma Recurrent
    • B-cell Chronic Lymphocytic Leukemia
    • Beijing, Beijing, China
    • +2 more
    Dec 6, 2018

    Chronic Lymphocytic Leukemia Electronic Patient Reported

    Completed
    • CLL
    • Carevive CPS
    • Tampa, Florida
      Moffitt Cancer Institute
    Aug 23, 2019

    Waldenstrom's Macroglobulinemia Trial in Boston (GS-1101)

    Terminated
    Has Results
    • Waldenstrom's Macroglobulinemia
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Nov 14, 2016

    Chronic Lymphocytic Leukemia (CLL) Trial in Worldwide (Idelalisib, Rituximab)

    Approved for marketing
    • Chronic Lymphocytic Leukemia (CLL)
    • La Jolla, California
    • +7 more
    Oct 27, 2014

    Hematological Malignancies Trial in Pavia

    Unknown status
    • Hematological Malignancies
      • Pavia, Italy
        Department of Hematology Oncology, IRCCS Policlinico San Matteo
      Jun 4, 2015

      Chronic Lymphocytic Leukemia Trial (GS-1101)

      Withdrawn
      • Chronic Lymphocytic Leukemia
      • (no location specified)
      Sep 6, 2012

      Chronic Lymphocytic Leukemia (CLL), Lymphoma, Non-Hodgkin (NHL), Acute Myeloid Leukemia (AML) Trial in United States (CAL-101)

      Completed
      • Chronic Lymphocytic Leukemia (CLL)
      • +3 more
      • Palo Alto, California
      • +8 more
      Aug 29, 2012